ClassID:

21647

A61K2300/00 - page 33 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#9601
20110052737
2011-03-03

Topical skin care formulations comprising botanical extracts

#9602
20110052736
2011-03-03

Methods and materials for reducing or eliminating risk factors associated with syndrome X

#9603
20110052733
2011-03-03

HERBAL COMPOSITIONS FOR THE TREATMENT OF MUCOSAL LESIONS

#9604
20110052732
2011-03-03

MINERAL ABSORPTION ACCELERATOR AND IRON DEFICIENCY ANEMIA IMPROVER OF FOOD COMPOSITION

#9605
20110052730
2011-03-03

Leaves Extract of Panax sp., a Process of Making the Same and Uses Thereof

#9606
20110052729
2011-03-03

Pharmaceutical or nutraceutical composition

#9607
20110052727
2011-03-03

Anti Influenza Nutritional Supplements

#9608
20110052725
2011-03-03

THERAPEUTIC AGENT FOR INFECTIOUS SKIN AND MUCOSAL DISEASE

#9609
20110052722
2011-03-03

Toleration Iron Supplement Compositions

#9610
20110052721
2011-03-03

Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses

#9611
20110052718
2011-03-03

Synergistic Phytoceutical Compositions

#9612
20110052711
2011-03-03

Controlled release multidrug formulations for spinal cord injury

#9613
20110052707
2011-03-03

COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3

#9614
20110052706
2011-03-03

Pancreatine pellets and method of producing same

#9615
20110052704
2011-03-03

Tocotrienol compositions

#9616
20110052695
2011-03-03

DRUG DELIVERY PLATFORMS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF

#9617
20110052689
2011-03-03

SUSTAINED RELEASE OF GUAIFENESIN

#9618
20110052684
2011-03-03

PHARMACEUTICAL COMPOSITION

#9619
20110052683
2011-03-03

PHARMACEUTICAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASE

#9620
20110052678
2011-03-03

METHOD FOR TREATING AGE RELATED MACULAR DEGENERATION

#9621
20110052664
2011-03-03

Antimicrobial medical dressings and protecting wounds and catheter sites

#9622
20110052659
2011-03-03

Implants for administering substances and methods of producing mesoporous implants

#9623
20110052657
2011-03-03

Implants for administering substances and methods of producing implants

#9624
20110052651
2011-03-03

Antimicrobial compositions and products

#9625
20110052632
2011-03-03

HIV POLYNUCLEOTIDES AND POLYPEPTIDES DERIVED FROM BOTSWANA MJ4

#9626
20110052631
2011-03-03

INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS

#9627
20110052628
2011-03-03

Recombinant Double-Stranded RNA Phage, and Use of the Same

#9628
20110052625
2011-03-03

COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE ANALOGS AND ISLET NEOGENESIS ASSOCIATED PEPTIDE

#9629
20110052613
2011-03-03

Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase

#9630
20110052592
2011-03-03

Compositions and methods for use for antibodies against sclerostin

#9631
20110052581
2011-03-03

USE OF PICOPLATIN AND CETUXIMAB TO TREAT COLORECTAL CANCER

#9632
20110052580
2011-03-03

USE OF PICOPLATIN AND BEVACIZUMAB TO TREAT COLORECTAL CANCER

#9633
20110052576
2011-03-03

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

#9634
20110052574
2011-03-03

METHOD OF INHIBITION OF LEUKEMIC STEM CELLS

#9635
20110052568
2011-03-03

Tablet comprising natural allicin and method for producing the same

#9636
20110052561
2011-03-03

OSTEOLYSIS TREATMENT

#9637
20110052557
2011-03-03

Treating a bacteria-induced gastric disorder with a mixture having pomegranate and hydrogen peroxide

#9638
20110052556
2011-03-03

PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND CARNITINE AND PROCESS FOR ITS PREPARATION

#9639
20110052554
2011-03-03

Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors

#9640
20110052550
2011-03-03

Therapeutic uses of allogeneic myeloid progenitor cells

#9641
20110052547
2011-03-03

Rapamycin-resistant T cells and therapeutic uses thereof

#9642
20110052538
2011-03-03

PROBIOTIC/NON-PROBIOTIC COMBINATIONS

#9643
20110052536
2011-03-03

Methods of treating a family viral infection and compositions for treating a family viral infection

#9644
20110052535
2011-03-03

COMPOSITIONS FOR TREATING AN INFLAMMATORY AUTOIMMUNE CONDITION

#9645
20110052533
2011-03-03

Compositions and Methods for Cartilage Repair

#9646
20110052532
2011-03-03

Pharmaceutical composition comprising a cytokine

#9647
20110052531
2011-03-03

Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy

#9648
20110052530
2011-03-03

Adoptive cell therapy with young T cells

#9649
20110052529
2011-03-03

METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS

#9650
20110052526
2011-03-03

Method and composition for neochondrogenesis

#9651
20110052515
2011-03-03

AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTION OF THE SKIN, E.G., ROSACEA

#9652
20110052503
2011-03-03

BIODEGRADABLE CONTRAST AGENTS

#9653
20110048980
2011-03-03

Fatty Acid Oxidation Inhibitors Treating Hyperglycemia and Related Disorders

#9654
20110047633
2011-02-24

Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins

#9655
20110047103
2011-02-24

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER

#9656
20110046579
2011-02-24

Derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites

#9657
20110046532
2011-02-24

COMPOSITION INCLUDING A SILICONE-BASED POLYMER AND A METHOD OF TREATING SKIN DISORDERS USING THE COMPOSITION

#9658
20110046482
2011-02-24

METHODS FOR REDUCING TOXICITIES ASSOCIATED WITH MEDICAL PROCEDURES EMPLOYING RADIOGRAPHIC CONTRAST AGENTS

#9659
20110046228
2011-02-24

METHODS FOR ADMINISTRATION OF COLCHICINE WITH GRAPEFRUIT JUICE

#9660
20110046227
2011-02-24

METHODS FOR CONCOMITANT ADMINISTRATION OF COLCHICINE AND A SECOND ACTIVE AGENT

#9661
20110046223
2011-02-24

TREATMENT OF NEUROFIBROMATOSIS

#9662
20110046215
2011-02-24

ABNORMAL INTRAOCULAR PRESSURE TREATMENT

#9663
20110046211
2011-02-24

COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS

#9664
20110046192
2011-02-24

Therapeutic drug for hypertension or prehypertension

#9665
20110046191
2011-02-24

COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST

#9666
20110046190
2011-02-24

COMBINATIONS COMPRISING A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR

#9667
20110046173
2011-02-24

COMBINATION ANALGESIC OPIOID PAIN THERAPY

#9668
20110046172
2011-02-24

Medicinal Compositions

#9669
20110046156
2011-02-24

TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS

#9670
20110046150
2011-02-24

USE OF N--4-(3-PYRIDYL)-2-PYRIDINE-AMINE FOR THE TREATMENT OF PULMONARY HYPERTENSION

#9671
20110046141
2011-02-24

USE OF PDE5 INHIBITORS FOR TREATING CIRCADIAN RHYTHM DISORDERS

#9672
20110046125
2011-02-24

METHOD FOR TREATING INFECTIONS

#9673
20110046119
2011-02-24

THERAPEUTIC TREATMENT

#9674
20110046117
2011-02-24

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

#9675
20110046116
2011-02-24

SEDATIVE FOR USE DURING EYE SURGERY

#9676
20110046099
2011-02-24

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

#9677
20110046096
2011-02-24

Piperazinodihydrothienopyrimidine derivatives

#9678
20110046095
2011-02-24

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

#9679
20110046091
2011-02-24

COMPOSITION AND METHODS USED DURING ANTI-HIV TREATMENT

#9680
20110046090
2011-02-24

MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS

#9681
20110046081
2011-02-24

Classical cannabinoid metabolites and methods of use thereof

#9682
20110046079
2011-02-24

Use of Proton Pump Inhibitors as Drug Delivery Adjuvants

#9683
20110046076
2011-02-24

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#9684
20110046072
2011-02-24

SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE

#9685
20110046071
2011-02-24

GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer

#9686
20110046053
2011-02-24

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE

#9687
20110046046
2011-02-24

PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR DIABETES OR OBESITY

#9688
20110046041
2011-02-24

Methods of inhibiting and treating biofilms using glycopeptide antibiotics

#9689
20110046039
2011-02-24

POST-EXPOSURE PROPHYLAXIS AND TREATMENT OF INFECTIONS

#9690
20110046033
2011-02-24

Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function

#9691
20110045583
2011-02-24

Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

#9692
20110045568
2011-02-24

METHOD FOR RESTORING BMP-RECEPTOR SIGNALING IN A CELL

#9693
20110045111
2011-02-24

Composition comprising the extracts of for prevention and treatment of cardiovascular diseases

#9694
20110045108
2011-02-24

ANTI-DIABETIC EXTRACT OF HONEYBUSH

#9695
20110045107
2011-02-24

Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines

#9696
20110045102
2011-02-24

Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide

#9697
20110045099
2011-02-24

NUTRACEUTICAL COMPOSITION AND METHODS OF USE

#9698
20110045089
2011-02-24

VITAMIN K3 DERIVATIVE / NSA FORMULATION

#9699
20110045082
2011-02-24

AGGLOMERATES BY CRYSTALLISATION

#9700
20110045077
2011-02-24

ENCAPSULATED PANCREATIC ISLET CELL PRODUCTS AND METHODS OF USE THEREOF

#9701
20110045073
2011-02-24

METHODS AND COMPOSITIONS OF SPHINGOLIPID FOR PREVENTING AND TREATING MICROBIAL INFECTIONS

#9702
20110045070
2011-02-24

Combination therapy

#9703
20110045066
2011-02-24

Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus

#9704
20110045062
2011-02-24

FORMULATION

#9705
20110045049
2011-02-24

Immunomodulating compositions and methods of use

#9706
20110045033
2011-02-24

Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders

#9707
20110045032
2011-02-24

COMPOSITION, FORMULATIONS & KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH DEHYDROEPIANDROSTERONE(S) STEROID & AN ANTI-MUSCARINIC AGENT(S)

#9708
20110045014
2011-02-24

ACCELERATION AGENT OF CALCIUM ABSORPTION

#9709
20110045002
2011-02-24

METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION

#9710
20110044998
2011-02-24

Stabilized angiopoietin-2 antibodies and uses thereof

#9711
20110044997
2011-02-24

Methods for mobilizing mesenchymal stem cells in a patient

#9712
20110044975
2011-02-24

TREATMENT OF PRION PROTEIN RELATED DISEASES

#9713
20110044971
2011-02-24

Method and composition for treating a serotonin receptor-mediated condition

#9714
20110044969
2011-02-24

Antimicrobial Agents for the Treatment of Campylobacter Species in the Crop of a Bird

#9715
20110044966
2011-02-24

Use of a substance for manufacturing of a medicament for treatment of common cold

#9716
20110044965
2011-02-24

L-citrulline for treating endothelial dysfunction and erectile dysfunction

#9717
20110044952
2011-02-24

AMPLIFICATION OF CANCER-SPECIFIC ONCOLYTIC VIRAL INFECTION BY HISTONE DEACETYLASE INHIBITORS

#9718
20110044950
2011-02-24

Infusion of a Mixture of Autologous Bone Marrow-Derived Mononuclear Cells and Autologous or Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Treating Myocardial and/or Cardiovascular Disorders

#9719
20110044949
2011-02-24

Oncolytic virus replicating selectively in tumor cells

#9720
20110044948
2011-02-24

Poxviral oncolytic vectors

#9721
20110044947
2011-02-24

METHODS OF TREATING CARDIAC DISORDERS

#9722
20110044945
2011-02-24

AGENTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND METHODS OF USING SAME

#9723
20110044944
2011-02-24

Anti-inflammatory compositions for treating brain inflammation

#9724
20110044941
2011-02-24

IMMUNOTHERAPY FOR REVERSING IMMUNE SUPPRESSION

#9725
20110044939
2011-02-24

REGULATORY T CELLS IN ADIPOSE TISSUE

#9726
20110044937
2011-02-24

STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY

#9727
20110044917
2011-02-24

Dental composition for treating peri-implantitis

#9728
20110044908
2011-02-24

Methods and compositions for treating and identifying compounds to treat age-related macular degeneration

#9729
20110044895
2011-02-24

METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS

#9730
20110043832
2011-02-24

Printed audio format and photograph with encoded audio

#9731
20110040289
2011-02-17

Wound care device having fluid transfer properties

#9732
20110039940
2011-02-17

Methods for Concomitant Administration of Colchicine and a Second Active Agent

#9733
20110039935
2011-02-17

USE OF PHARMACOLOGICALLY ACTIVE CHEMICAL COMPOUNDS

#9734
20110039930
2011-02-17

FAST-ACTING NAPROXEN COMPOSITION WITH REDUCED GASTROINTESTINAL EFFECTS

#9735
20110039928
2011-02-17

Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition

#9736
20110039906
2011-02-17

ANTIBACTERIAL COMBINATION THERAPY

#9737
20110039875
2011-02-17

Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy

#9738
20110039868
2011-02-17

Inhibitors of Bruton's tyrosine kinase

#9739
20110039863
2011-02-17

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS

#9740
20110039850
2011-02-17

Leukemia Treatment

#9741
20110039813
2011-02-17

Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components

#9742
20110039811
2011-02-17

TREATING HYPERGLYCEMIA WITH 25-HYDROXYVITAMIN D3

#9743
20110039810
2011-02-17

USE OF 25-HYDROXY-VITAMIN D3 TO AFFECT HUMAN MUSCLE PHYSIOLOGY

#9744
20110039806
2011-02-17

COMBINED THERAPIES OF ANTIPSYCHOTIC DRUGS AND TETRACYCLINES IN THE TREATMENT OF PSYCHIATRIC DISORDERS

#9745
20110039804
2011-02-17

Composition of Risedronate and Vitamin D3

#9746
20110039796
2011-02-17

Natural Composition for Anti-Angiogenesis and Anti-Obesity

#9747
20110039790
2011-02-17

Enhanced ocular neuroprotection and neurostimulation

#9748
20110039788
2011-02-17

COMPOSITIONS, METHODS AND KITS FOR DETECTING AND TREATING CANCER

#9749
20110039781
2011-02-17

Treatment of conditions related to cecal ligation shock

#9750
20110039759
2011-02-17

Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)

#9751
20110039293
2011-02-17

Effervescent Solid Pharmaceutical Composition Comprising Dextrose and Process for its Preparation

#9752
20110038969
2011-02-17

Fermented composition of mung bean hulls, method for forming thereof, and anti-oxidation and anti-inflammation composition using the same

#9753
20110038965
2011-02-17

Topical formulation and uses thereof

#9754
20110038963
2011-02-17

Combined effects of nutrients on proliferation of stem cells

#9755
20110038962
2011-02-17

Dietary supplements and methods for treating pain and inflammation

#9756
20110038958
2011-02-17

Use of cannabinoids in combination with an anti-psychotic medicament

#9757
20110038955
2011-02-17

PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE

#9758
20110038951
2011-02-17

Anti-tumor drug, medicament, composition, and use thereof

#9759
20110038949
2011-02-17

HOMEOPATHIC FORMULATION

#9760
20110038948
2011-02-17

Methods of Reducing the Production of Reactive Oxygen Species and Methods of Screening or Identifying Compounds and Compositions that Reduce the Production of Reactive Oxygen Species

#9761
20110038945
2011-02-17

Orally ingestable medicament and method for treating a heartburn inducing event or an acid reflux episode in a living human subject

#9762
20110038940
2011-02-17

PULVERULENT COMPOSITION AND A PROCESS FOR PREPARING THE SAME

#9763
20110038931
2011-02-17

COMPOSITE PREPARATION

#9764
20110038921
2011-02-17

METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD

#9765
20110038917
2011-02-17

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING GRAM-NEGATIVE BACTERIAL INFECTIONS

#9766
20110038910
2011-02-17

ANTI-INFECTIVE ANTIMICROBIAL-CONTAINING BIOMATERIALS

#9767
20110038906
2011-02-17

Aloe powder, aloe juice, and method for producing the same

#9768
20110038898
2011-02-17

DISSOLUTION PROPERTIES OF DRUG PRODUCTS CONTAINING OLMESARTAN MEDOXOMIL

#9769
20110038888
2011-02-17

ADJUVANT COMPOSITIONS COMPRISING POLY-IC AND A CATIONIC POLYMER

#9770
20110038880
2011-02-17

PARASPORIN-1 RECEPTOR AND USE THEREOF

#9771
20110038858
2011-02-17

METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS

#9772
20110038856
2011-02-17

METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES

#9773
20110038851
2011-02-17

Treatment of synucleinopathies

#9774
20110038848
2011-02-17

DIETARY SUPPLEMENT COMPOSITIONS FOR CARDIOVASCULAR HEALTH

#9775
20110038846
2011-02-17

Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition

#9776
20110038832
2011-02-17

METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE

#9777
20110038831
2011-02-17

Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators

#9778
20110038813
2011-02-17

Compositions against alkyl-acyl GPC, the derivatives and products thereof

#9779
20110038806
2011-02-17

MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A STEROID

#9780
20110038800
2011-02-17

Method for the treatment of lymphangioleiomyomatosis (LAM)

#9781
20110038791
2011-02-17

METHODS FOR INHIBITING SIX1 AND EYA PROTEINS

#9782
20110035232
2011-02-10

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#9783
20110034859
2011-02-10

Iontophoresis preparation for treating breast cancer and/or mastitis

#9784
20110034752
2011-02-10

THERAPEUTIC REGIMEN FOR TREATING CANCER

#9785
20110034565
2011-02-10

PSYCHO-PHARMACEUTICALS

#9786
20110034563
2011-02-10

Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect

#9787
20110034562
2011-02-10

Psycho-pharmaceuticals

#9788
20110034555
2011-02-10

Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy

#9789
20110034519
2011-02-10

Nutritional supplements

#9790
20110034518
2011-02-10

Pharmaceutical composition

#9791
20110034508
2011-02-10

Treatment of BDNF-related disorders using laquinimod

#9792
20110034504
2011-02-10

AGENT FOR PREVENTING AND/OR TREATING VASCULAR DISEASES

#9793
20110034480
2011-02-10

COMPOSITIONS COMPRISING CETIRIZINE AND A NON BETA-2-ADRENORECEPTOR AGONIST, A BETA-2-ADRENORECEPTOR AGONIST OR AN ANTI-INFLAMMATORY AND THE USE THEREOF FOR THE TREATMENT OF RESPIRATORY DISORDERS

#9794
20110034471
2011-02-10

Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment

#9795
20110034442
2011-02-10

Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders

#9796
20110034425
2011-02-10

Method of treatment for acute myelogenous leukemia

#9797
20110034424
2011-02-10

METHOD FOR THE LONG TERM NSAID USE

#9798
20110034423
2011-02-10

Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists

#9799
20110034415
2011-02-10

WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS

#9800
20110034411
2011-02-10

Methods and compositions for improving gastrointetinal health

#9801
20110034392
2011-02-10

Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same

#9802
20110034386
2011-02-10

DENDROASPIS NATRIURETIC PEPTIDE FOR TREATMENT OF CANCER

#9803
20110034384
2011-02-10

COMBINATION VEGFR2 THERAPY WITH mTOR INHIBITORS

#9804
20110034382
2011-02-10

Use of liver growth factor (LGF) as a neural tissue regenerator

#9805
20110034380
2011-02-10

COMBINATION OF A SELECTIVE PPAR-GAMMA MODULATOR AND AN INCRETIN FOR THE TREATMENT OF DIABETES AND OBESITY

#9806
20110034379
2011-02-10

Gastrin Compositions And Formulations, And Methods Of Use And Preparation

#9807
20110034378
2011-02-10

Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.

#9808
20110034377
2011-02-10

Exendin and exendin agonists for eating disorders

#9809
20110034373
2011-02-10

USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY

#9810
20110033595
2011-02-10

Fatty acid fractionation process, fatty acid products and use thereof

#9811
20110033565
2011-02-10

Protective compositions for dermal papilla cells

#9812
20110033559
2011-02-10

Dietary Calcium for Reducing the Production of Reactive Oxygen Species

#9813
20110033557
2011-02-10

PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF

#9814
20110033545
2011-02-10

TOPICAL PHARMACEUTICAL PREPARATIONS HAVING BOTH A NANOPARTICLE SOLUTION AND A NANOPARTICLE SUSPENSION AND METHODS FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN THEREWITH

#9815
20110033541
2011-02-10

Sublingual and buccal film compositions

#9816
20110033526
2011-02-10

PHARMACEUTICAL COMPOSITION OF ANTIBIOTICS AND PREBIOTICS FOR PREVENTING AND TREATING DYSBIOSIS DURING ANTIBACTERIAL THERAPY

#9817
20110033519
2011-02-10

Device with Aromatase Inhibitor for the Treatment and Prevention of Uterine Fibroids and Method of Use

#9818
20110033516
2011-02-10

METHODS AND COMPOSITIONS FOR BONE HEALING BY PERIOSTIN

#9819
20110033504
2011-02-10

ARTICLES AND METHODS FOR REPAIRING DAMAGED NERVOUS TISSUE

#9820
20110033491
2011-02-10

Multicomponent meningococcal vaccine

#9821
20110033475
2011-02-10

Use of beta-glucans against biological warfare weapons and pathogens including anthrax

#9822
20110033474
2011-02-10

INHIBITION OF PLATELET AGGREGATION

#9823
20110033463
2011-02-10

APHERESIS, ADMINISTRATION OF AGENT, OR COMBINATION THEREOF

#9824
20110033461
2011-02-10

Combination Therapy for the Treatment of Cancer

#9825
20110033459
2011-02-10

Combination therapy with a compound acting as a platelet ADP receptor inhibitor

#9826
20110033458
2011-02-10

COMBINATIONS COMPRISING EPOTHILONES AND PHARMACEUTICAL USES THEREOF

#9827
20110033457
2011-02-10

COMBINATION OF EPOTHILONE ANALOGS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#9828
20110033454
2011-02-10

Methods For Treating Diseases Using Antibodies to Aminophospolipids

#9829
20110033453
2011-02-10

USE OF PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS

#9830
20110033423
2011-02-10

Probiotics for use in relieving symptoms associated with gastronitestinal disorders

#9831
20110033422
2011-02-10

TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION

#9832
20110033421
2011-02-10

METHODS RELATED TO IMMUNOSTIMULATORY NUCLEIC ACID-INDUCED INTERFERON

#9833
20110033420
2011-02-10

Macrocyclic compounds as hepatitis C virus inhibitors

#9834
20110033419
2011-02-10

Methods and compositions for treating cancer

#9835
20110033418
2011-02-10

TREATMENT OF DISEASES CAUSED BY VIRAL INFECTION

#9836
20110033414
2011-02-10

Cardiovascular therapy compositions

#9837
20110033402
2011-02-10

Solubilized benzoyl small molecule

#9838
20110033399
2011-02-10

Therapeutic vitamin D sun-protecting formulations and methods for their use

#9839
20110033395
2011-02-10

AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#9840
20110033394
2011-02-10

Oral compositions and methods

#9841
20110033376
2011-02-10

Treatment of Melanoma

#9842
20110028564
2011-02-03

Compositions and methods for treatment of filovirus-mediated diseases

#9843
20110028563
2011-02-03

Anti-microbial composition

#9844
20110028548
2011-02-03

BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW

#9845
20110028543
2011-02-03

Formulations and methods of using nitric oxide mimetics in cancer treatment

#9846
20110028536
2011-02-03

METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION

#9847
20110028532
2011-02-03

Methods of treating eye diseases in diabetic patients

#9848
20110028505
2011-02-03

COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS

#9849
20110028504
2011-02-03

Formulation of radioprotective alpha beta unsaturated aryl sulfones

#9850
20110028503
2011-02-03

COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY

#9851
20110028488
2011-02-03

Combination product comprising SRC kinase inhibitor AZDO530 and an antioestrogen or EGFR-TK-inhibitor

#9852
20110028471
2011-02-03

COMBINATION THERAPY 238

#9853
20110028451
2011-02-03

Dihydrobenzoindazoles

#9854
20110028450
2011-02-03

Ring-annulated dihydropyrrolo[2,1-α]isoquinolines

#9855
20110028439
2011-02-03

Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer

#9856
20110028436
2011-02-03

Oral combination of vitamins

#9857
20110028429
2011-02-03

COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA

#9858
20110028422
2011-02-03

COMBINATION OF NILOTINIB AND A NITROGEN MUSTARD ANALOGUE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

#9859
20110028421
2011-02-03

Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

#9860
20110028413
2011-02-03

Methods of Reducing Methotrexate Nephrotoxicity

#9861
20110028412
2011-02-03

Herbal enhanced analgesic formulations

#9862
20110028385
2011-02-03

Combination of immunomodulator and anti-pathogenic agent

#9863
20110027424
2011-02-03

Microbially-stable vitamin E solutions

#9864
20110027399
2011-02-03

Antiviral Agent and Antiviral Composition

#9865
20110027397
2011-02-03

Methods of treating autism spectrum disorders and compositions for same

#9866
20110027391
2011-02-03

Liquid nucleotides/nucleosides-containing product

#9867
20110027390
2011-02-03

Methods for Reducing Cisplatin Nephrotoxicity

#9868
20110027388
2011-02-03

Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola Virus

#9869
20110027387
2011-02-03

Nutritional supplement for use with poultry and livestock

#9870
20110027384
2011-02-03

Photosensitising composition and its uses

#9871
20110027382
2011-02-03

Solubilized benzoyl peroxyde acne

#9872
20110027381
2011-02-03

Treatment of osteoporosis

#9873
20110027378
2011-02-03

Process of making flowable hemostatic compositions and devices containing such compositions

#9874
20110027369
2011-02-03

PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE INGREDIENTS

#9875
20110027363
2011-02-03

Nouvelle forme d'administration de proteines osteogeniques

#9876
20110027348
2011-02-03

COMPOSITION AND METHOD INHIBITING INFLAMMATION

#9877
20110027340
2011-02-03

Implantable drug depot for weight control

#9878
20110027305
2011-02-03

Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus

#9879
20110027295
2011-02-03

Adenosine receptor agonists and antagonists to modulate T cell responses

#9880
20110027287
2011-02-03

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#9881
20110027286
2011-02-03

High affinity human antibodies to human angiopoietin-2

#9882
20110027285
2011-02-03

METHODS AND AGENTS MODULATING UPA/UPAR ACTIVITY

#9883
20110027262
2011-02-03

PLATFORM ANTIBODY COMPOSITIONS

#9884
20110027257
2011-02-03

CLOTTABLE CONCENTRATE OF PLATELET GROWTH FACTORS AND PREPARATION METHOD THEREOF

#9885
20110027255
2011-02-03

Composition and method for treating papilloma virus and equine sarcoids

#9886
20110027251
2011-02-03

NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

#9887
20110027243
2011-02-03

COMPOSITION BASED ON PROBIOTIC BACTERIA IN ASSOCIATION WITH A PREBIOTIC AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF RESPIRATORY PATHOLOGIES AND/OR INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY

#9888
20110027239
2011-02-03

ADIPOSE-DERIVED STROMAL CELLS (ASC) AS DELIVERY TOOL FOR TREATMENT OF CANCER

#9889
20110027236
2011-02-03

Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases

#9890
20110027230
2011-02-03

COMPOSITIONS COMPRISING PHYTOESTROGENES SELECTIVE FOR ESTROGEN BETA RECEPTOR AND DIETARY FIBRES

#9891
20110027229
2011-02-03

CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-ALPHA TO HEPATITIS C INFECTED PATIENTS

#9892
20110027225
2011-02-03

MN/CA IX and EGFR Pathway Inhibition

#9893
20110027224
2011-02-03

USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA

#9894
20110027221
2011-02-03

Skincare composition comprising HSA fusion protein, preparation method and uses thereof

#9895
20110027201
2011-02-03

Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists

#9896
20110023876
2011-02-03

Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems

#9897
20110023661
2011-02-03

BIO-CO-CR-MO ALLOY WITH ION ELUTION SUPPRESSED BY STRUCTURE CONTROL, AND PROCESS FOR PRODUCING SAME

#9898
20110021974
2011-01-27

RETINITIS PIGMENTOSA TREATMENT AND PROPHALAXIS

#9899
20110021770
2011-01-27

Fungus polyose composition with immunity enhancing effect and application thereof

#9900
20110021637
2011-01-27

XANTHOHUMOL AND TETRAHYDRO-ISOALPHA ACID BASED PROTEIN KINASE MODULATION CANCER TREATMENT